Elanco Animal Health Incorporated 2025-2026 Proxy Voting Records

Description as filed by funds: Election of two Class I director nominees and three Class II director nominees: Class I Nominees: Kapila Anand

Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Kapila K. Anand”): 375,459,071 for, 91,840,502 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 109 asset managers below reported 227,770,641 for, 60,795,821 against, 82,174 abstained, 419 not voted.

Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.

Description as filed by funds: Election of two Class I director nominees and three Class II director nominees: Class I Nominees: Paul Herendeen

Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Paul Herendeen”): 441,252,058 for, 26,575,629 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 109 asset managers below reported 280,795,042 for, 7,771,421 against, 82,173 abstained, 419 not voted.

Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.

Description as filed by funds: Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Kirk McDonald

Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Kirk McDonald”): 440,842,458 for, 26,978,663 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 109 asset managers below reported 280,795,042 for, 7,771,421 against, 82,173 abstained, 419 not voted.

Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.

Description as filed by funds: Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Lawrence Kurzius

Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Lawrence Kurzius”): 442,964,897 for, 24,863,542 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 109 asset managers below reported 280,795,047 for, 7,771,416 against, 82,173 abstained, 419 not voted.

Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.

Description as filed by funds: Election of two Class I director nominees and three Class II director nominees: Class II Nominees: Michael Harrington

Elanco Animal Health Incorporated’s own tally for this item (“Elect Director: Michael Harrington”): 373,406,333 for, 94,421,261 against, per its Form 8-K filed May 27, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “All of the nominees nominated by the Board for director were elected to serve for a one-year term ending at the 2027 annual meeting of shareholders and until their respective successors are elected and qualified, by the votes set forth in the table below.”
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 109 asset managers below reported 227,484,486 for, 61,081,977 against, 82,173 abstained, 419 not voted.

Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.

Description as filed by funds: Advisory vote on the compensation of the company's named executive officers.

Elanco Animal Health Incorporated’s own tally for this item (“3. By non-binding vote, the compensation of Elanco's named executive officers”): 383,528,222 for, 84,173,798 against — passed, per its Form 8-K filed May 27, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders approved, by non-binding vote, the compensation of Elanco's named executive officers, by the votes set forth in the table below.”
Support: 82% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 107 managers: 228,012,403 for, 60,336,759 against, 82,173 abstained, 419 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 416 managers: 248,870,754 for, 79,732,671 against, 37 abstained, 143,892 not voted. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2026.

Elanco Animal Health Incorporated’s own tally for this item (“2. The appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2026”): 480,470,647 for, 2,611,450 against — passed, per its Form 8-K filed May 27, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The shareholders ratified the appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2026, by the votes set forth in the table below.”
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 110 asset managers below reported 288,492,324 for, 129,770 against, 82,173 abstained, 419 not voted.

Showing the 25 largest of 110 asset managers. See all 110 in the interactive database.